Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species

Mycoses

Volumn 42, Issue 9-10, 1999, Pages 539-542

  Kauffman, Carol A ^a,b   Zarins, Lidija T ^a  

^a Division of Infectious Diseases   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alamar Blue; Candida; Colorimetric assay; Susceptibility testing; Triazoles; Voriconazole

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDIASIS; COLORIMETRY; DILUTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA; COLORIMETRY; COLORING AGENTS; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; OXAZINES; PYRIMIDINES; TRIAZOLES; XANTHENES;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; ISSATCHENKIA ORIENTALIS;

EID: 0032704825     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.1999.00511.x     Document Type: Article

References (19)

1. 1 Ruhnke, M., Schmidt-Westhausen, A. & Trautmann, M. (1997) In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and-resistant Candida albicans from oral cavities of patients with human immunodeficiency virus infection. Antimicrob. Agents Chemother. 41, 575-577.
2. 2 Barry, A. L. & Brown, S. D. (1996) In vitro studies of two triazole antifungal agents (Voriconazole [UK-109,496] and fluconazole) against Candida species. Antimicrob. Agents Chemother. 40, 1948-1949.
3. 3 Espinel-Ingroff, A. (1998) In vitro activity of a new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi in common and emerging yeast pathogens. J. Clin. Microbiol. 36, 198-202.
4. 4 Kauffman, C. A. & Zarins, L. T. (1998) In vitro activity of voriconazole against Candida species. Diagn. Microbiol. Infect. Dis. 31, 297-300.
5. 5 Marco, F., Pfaller, M. A., Messer, S. & Jones, R. N. (1998) In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp. Antimicrob. Agents Chemother. 42, 161-163.
6. 6 McGinnis, M. R., Pasarell, L., Sutton, D. A., Fothergill, A. W., Cooper, C. R. & Rinaldi, M. G. (1997) In vitro evaluation of voriconazole against some clinically important fungi. Antimicrob. Agents Chemother. 41, 1832-1834.
7. 7 Revankar, S. G., Kirkpatrick, W. R., McAtee, R. K., et al. (1998) Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards methods. J. Clin. Microbiol. 36, 153-156.
8. 8 Rex, J. H., Nelson, P. W., Paetznick, V. L., Lozano-Chiu, M., Espinel-Ingroff, A. & Anaissie, E. J. (1998). Optimizing the correlation between results of testing in vitro and therapeutic outcomes in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis. Antimicrob. Agents Chemother. 42, 129-134.
9. 9 Pfaller, M. A., Grant, C., Morthland, V. & Rhine-Chalberg, J. (1994) Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole: against Candida albicans. J. Clin. Microbiol. 32, 506-509.
10. 10 Pfaller, M. A., Vu, Q., Lancaster, M., et al. (1994) Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32, 1625-1628.
11. 11 Pfaller, M. A. & Barry, A. L. (1994) Evaluation of a novel colorimetric broth microdilution method of antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32, 1992-1996.
12. 12 Tiballi, R. N., Zarins, L. T., He, X. & Kauffman, C. A. (1995) Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assays. J. Clin. Microbiol. 33, 2612-2615.
13. 13 Tiballi, R. N., He, X., Zarins, L. T., Revankar, S. G. & Kauffman, C. A. (1995) Use of a colorimetric system for yeast susceptibility testing. J. Clin. Microbiol. 33, 915-917.
14. 14 Arikan, S., Gür, D. & Akova, M. (1997) Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients. Mycoses 40, 291-296.
15. 15 Jones, P. G., Kauffman, C. A., McAuliffe, M. S., Liepman, M. K. & Bergman, A. G. (1984) Efficacy of ketoconazole versus nystatin for the prevention of fungal infections in neutropenic patients. Arch. Intern. Med. 144, 549-551.
16. 16 Kauffman, C. A., Liepman, M. K., Bergman, A. G. & Mioduszewski, J. (1983) Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients: reduction of infection and effect on bacterial and fungal flora. Am. J. Med. 74, 599-607.
17. 17 Sangeorzan, J. A., Bradley, S. F., He, X., et at. (1994) Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am. J. Med. 97, 339-347.
18. 18 Hedderwick, S. A., Wan, J. Y., Bradley, S. F., Sangeorzan, J. A., Terpenning, M. S. & Kauffman, C. A. (1998) Risk factors for colonization with yeast species in a long-term care facility. J. Am. Geriatr. Soc. 46, 849-853.
19. 19 National Committee for Clinical Laboratory Standards. (1997) Reference method for broth dilution anlifungal susceptibility testing for yeasts. Approved standard M27-A. Wayne, PA: National Committee for Clinical Laboratory Standards.